Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Moffitt Cancer Center, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591522288
